In this video, health-care analyst David Williamson discusses the briefing documents recently released by the FDA in advance of Delcath Systems and Aveo Pharmaceuticals advisory committee meetings. They range from damaging to devastating.
Watch and find out what sent shares of the two companies plummeting down 40% and 30% respectively and whether the sell-offs were deserved.
What macro trend was Warren Buffett referring to when he said "this is the tapeworm that's eating at American competitiveness"? Find out in our free report: "What's Really Eating at America's Competitiveness." You'll also discover an idea to profit as companies work to eradicate this efficiency-sucking tapeworm. Just click here for free, immediate access.
The article The FDA Firing Squad Takes Aim originally appeared on Fool.com.
David Williamson owns shares of Pfizer. Follow David on Twitter: @MotleyDavid.The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.